Supplier News: Enzene, Experic, ProMed & More
The latest from CDMOs, CMOs, and suppliers featuring Enzene, Experic, Made Scientific, Bora Pharmaceuticals, Made Scientific, Nusano, Quotient Sciences, Aenova and GXP Storage.
Chemicals/Chemical API Manufacturing
* Nusano Opens Radioisotope Production Facility
Biologics Manufacturing
* Enzene Opens New Continuous Biomanufacturing Facility in US
* Made Scientific Opens Cell-Therapy Mfg Facility
Formulation Development/Drug Product Manufacturing
* ProMed Pharma Acquires Mfg Facility from Bora Pharmaceuticals
* Quotient Sciences, CPI To Form RNA JV for Drug Products
* Aenova Expands Microbiology QC Lab
Appointments
* Experic Names Chief Commercial Officer
General
* GXP Storage Announces New UK Storage Facility
Chemicals/Chemical API Manufacturing
Nusano Opens Radioisotope Production Facility
Nusano, a producer of radioisotopes, has opened a 190,000-square-foot radioisotope production facility. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications.
Source: Nusano
Biologics Manufacturing
Enzene Opens New Continuous Biomanufacturing Facility in US
Enzene, a Pune, India-based CDMO of biologics, has opened a new continuous biomanufacturing facility in Hopewell, New Jersey. The new 80,000-square-foot facility is Enzene’s first major manufacturing investment in the US.
The site makes use of the company’s modular EnzeneX 2.0 platform for continuous biomanufacturing and also provides fed-batch biologics drug-substance manufacturing.
Source: Enzene
Made Scientific Opens Cell-Therapy Mfg Facility
Made Scientific, a CDMO of cell therapies, has opened a new 60,000-square-foot GMP manufacturing facility and headquarters in Princeton, New Jersey. The Princeton facility includes five ISO 7 / Grade B cleanrooms, in-house quality control labs, and dedicated process and analytical development capabilities.
The opening marks the completion of an initial $12-million investment in facility upgrades, equipment, and business system digitization. A second phase of expansion has already been announced, and the company says it expects to grow its workforce with more than 100 additional professionals.
As part of its broader expansion, Made Scientific’s recently announced an additional 12,000 square-foot build-out of GMP manufacturing cleanroom space. Once fully operational, the expansion will increase capacity by up to 2,000 additional batches per year to support late-phase and commercial programs. This expansion further establishes the company’s Princeton headquarters as a Center of Excellence for clinical-and-commercial supply.
Source: Made Scientific
Formulation Development/Drug Product Manufacturing
ProMed Pharma Acquires Mfg Facility from Bora Pharmaceuticals
ProMed Pharma, a supplier of drug-delivery services, has acquired a 28,000 square foot pharmaceutical manufacturing facility from Bora Pharmaceuticals.
The facility offers advanced infrastructure for GMP-compliant production, including controlled warehousing, Grade C and D manufacturing space, room for expansion, and capabilities that complement ProMed Pharma’s existing operations. The facility is expected to be fully operational by mid-2026.
Source: ProMed Pharma
Quotient Sciences, CPI To Form RNA JV for Drug Products
Quotient Sciences, a Nottingham, UK-based CDMO, and CPI, a UK technology innovation center, have signed a memorandum of understanding to form a joint venture (JV) aimed at accelerating the development of RNA-based therapies.
The JV will combine Quotient Sciences’ translational pharmaceutics platform with CPI’s expertise in small-scale manufacture of RNA and LNP encapsulation to deliver an integrated offering for the development of mRNA drug products.
The JV will integrate mRNA synthesis, LNP formulation development, clinical manufacturing, and early-phase clinical testing, all under one collaborative framework.
Source: Quotient Sciences
Aenova Expands Microbiology QC Lab
Aenova, a CDMO of drug products, has announced an expansion of its microbiology quality control (QC) laboratory at its site in Latina, Italy.
The project adds approximately 500 square meters of new laboratory space, bringing the total to around 800 square meters. With the expansion, Aenova will gain new and advanced laboratory capabilities. These include sterility testing for biologics using isolator technology, collection and trending of environmental monitoring data, bacterial ID technologies, and advanced techniques for monitoring viable particles, bioburden, and endotoxins.
The project creates positions for over 20 specialized analysts and technicians and allows the laboratory to test more than 1,000 batches per year.
Source: Aenova
Appointments
Experic Names Chief Commercial Officer
Experic, a Cranbury, New Jersey-based CDMO of drug products, has appointed Jeffrey Shane, current member of the Board of Directors, as its Chief Commercial Officer.
Shane brings nearly three decades of experience in biopharmaceutical manufacturing, including serving as President of the equipment manufacturer, Harro Höfliger, Experic’s long standing strategic equipment partner. He has also been a member of Experic’s Board of Directors since the company’s launch in 2018.
Source: Experic
General
GXP Storage Announces New UK Storage Facility
GXP-Storage, a provider of life-sciences materials storage, has announced a strategic expansion in the UK with a new storage site. The new site leverages GXP-Storage’s GXP-Guardian platform to ensure standardized operations and material visibility.
Source: GXP-Storage
